IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pompeu, M. M. L.
Right arrow Articles by Barral-Netto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pompeu, M. M. L.
Right arrow Articles by Barral-Netto, M.

 Previous Article  |  Next Article 

Infection and Immunity, December 2001, p. 7453-7460, Vol. 69, No. 12
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.12.7453-7460.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Differences in Gamma Interferon Production In Vitro Predict the Pace of the In Vivo Response to Leishmania amazonensis in Healthy Volunteers

M. M. L. Pompeu,1,2 C. Brodskyn,1,3 M. J. Teixeira,2 J. Clarêncio,1 J. Van Weyenberg,1 I. C. B. Coelho,2 S. A. Cardoso,1,4 A. Barral,1,4 and M. Barral-Netto1,4,*

Centro de Pesquisas Gonçalo Moniz (FIOCRUZ),1 Instituto de Ciências da Saúde da Universidade Federal da Bahia,3 and Faculdade de Medicina da Universidade Federal da Bahia,4 Salvador, Bahia, and Núcleo de Medicina Tropical, Universidade Federal do Ceará, Fortaleza, Ceará,2 Brazil

Received 14 May 2001/Returned for modification 7 July 2001/Accepted 25 August 2001

The initial encounter of Leishmania cells and cells from the immune system is fundamentally important in the outcome of infection and determines disease development or resistance. We evaluated the anti-Leishmania amazonensis response of naive volunteers by using an in vitro priming (IVP) system and comparing the responses following in vivo vaccination against the same parasite. In vitro stimulation allowed us to distinguish two groups of individuals, those who produced small amounts of gamma interferon (IFN-gamma ) (n = 16) (low producers) and those who produced large amounts of this cytokine (n = 16) (high producers). IFN-gamma production was proportional to tumor necrosis factor alpha and interleukin 10 (IL-10) levels but did not correlate with IL-5 production. Volunteers who produced small amounts of IFN-gamma in vitro remained low producers 40 days after vaccination, whereas high producers exhibited increased IFN-gamma production. However, 6 months after vaccination, all individuals tested produced similarly high levels of IFN-gamma upon stimulation of their peripheral blood mononuclear cells with Leishmania promastigotes, indicating that low in vitro producers respond slowly in vivo to vaccination. In high IFN-gamma producers there was an increased frequency of activated CD8+ T cells both in vitro and in vivo compared to the frequency in low producers, and such cells were positive for IFN-gamma as determined by intracellular staining. Such findings suggest that IVP responses can be used to predict the pace of postvaccination responses of test volunteers. Although all vaccinated individuals eventually have a potent anti-Leishmania cell-mediated immunity (CMI) response, a delay in mounting the CMI response may influence resistance against leishmaniasis.

* Corresponding author. Mailing address: Centro de Pesquisa Gonçalo Moniz (FIOCRUZ), Rua Valdemar Falcão, 121, Salvador, Bahia, Brazil, 40295-001. Phone: 55-71-356-4320, ext. 211. Fax: 55-71-356-2593. E-mail: barral{at}ufba.br.

Infection and Immunity, December 2001, p. 7453-7460, Vol. 69, No. 12
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.12.7453-7460.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2001 by the American Society for Microbiology. All rights reserved.